Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.81B |
| 2 |
Microsoft
MSFT
|
+$1.34B |
| 3 |
Apple
AAPL
|
+$1.25B |
| 4 |
Amazon
AMZN
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$480M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPLK
Splunk Inc
SPLK
|
+$373M |
| 2 |
Amgen
AMGN
|
+$204M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$180M |
| 4 |
IMGN
Immunogen Inc
IMGN
|
+$160M |
| 5 |
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.47% |
| 2 | Financials | 12.91% |
| 3 | Healthcare | 12.22% |
| 4 | Consumer Discretionary | 10.6% |
| 5 | Industrials | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
SkinHealth Systems
SKIN
$85.9M
| $8.42M | ﹤0.01% |
1,896,646
+21,020
| +1% | +$68.3K |
|
2427
Xponential Fitness
XPOF
$206M
| $8.4M | ﹤0.01% |
508,095
-14,566
| -3% | -$179K |
|
2428
FLEX LNG
FLNG
$1.64B
| $8.4M | ﹤0.01% |
330,261
+6,368
| +2% | +$174K |
|
2429
America's Car Mart
CRMT
$25.7M
| $8.38M | ﹤0.01% |
131,249
+2,407
| +2% | +$153K |
|
|
TBI
2430
Trueblue
TBI
$309M
| $8.36M | ﹤0.01% |
667,961
+10,060
| +2% | +$130K |
|
2431
Enliven Therapeutics
ELVN
$4.25B
| $8.36M | ﹤0.01% |
475,456
+10,799
| +2% | +$166K |
|
2432
Anika Therapeutics
ANIK
$283M
| $8.36M | ﹤0.01% |
329,163
+10,250
| +3% | +$248K |
|
2433
AMC Global Media
AMCX
$496M
| $8.36M | ﹤0.01% |
688,725
+15,518
| +2% | +$235K |
|
|
JBIO
2434
Jade Biosciences
JBIO
$1.51B
| $8.33M | ﹤0.01% |
8,050
+139
| +2% | +$106K |
|
|
SLRN
2435
DELISTED
ACELYRIN
SLRN
| $8.3M | ﹤0.01% |
1,229,995
+455,864
| +59% | +$3.46M |
|
2436
Build-A-Bear
BBW
$474M
| $8.28M | ﹤0.01% |
277,208
+803
| +0.3% | +$19.3K |
|
2437
Adaptive Biotechnologies
ADPT
$3.89B
| $8.28M | ﹤0.01% |
2,579,126
+55,484
| +2% | +$215K |
|
|
FFIC
2438
DELISTED
Flushing Financial
FFIC
| $8.28M | ﹤0.01% |
656,426
+12,573
| +2% | +$177K |
|
2439
Praxis Precision Medicines
PRAX
$10.3B
| $8.22M | ﹤0.01% |
134,717
+41,759
| +45% | +$1.87M |
|
2440
American Healthcare REIT
AHR
$10.3B
| $8.22M | ﹤0.01% |
+557,071
| New | +$7.66M |
|
|
CTLP
2441
DELISTED
Cantaloupe
CTLP
| $8.2M | ﹤0.01% |
1,275,006
+25,624
| +2% | +$169K |
|
2442
NovaGold Resources
NG
$3.4B
| $8.2M | ﹤0.01% |
2,732,172
+56,077
| +2% | +$158K |
|
2443
Bowman Consulting
BWMN
$731M
| $8.19M | ﹤0.01% |
235,402
+7,455
| +3% | +$257K |
|
|
INZY
2444
DELISTED
Inozyme Pharma
INZY
| $8.18M | ﹤0.01% |
1,067,479
+34,763
| +3% | +$191K |
|
|
OSG
2445
DELISTED
Overseas Shipholding Group Inc.
OSG
| $8.17M | ﹤0.01% |
1,277,179
+9,359
| +0.7% | +$55.9K |
|
2446
Capital City Bank Group
CCBG
$898M
| $8.17M | ﹤0.01% |
295,018
+5,763
| +2% | +$162K |
|
|
DSKE
2447
DELISTED
Daseke, Inc. Common Stock
DSKE
| $8.1M | ﹤0.01% |
975,714
+66,584
| +7% | +$545K |
|
2448
Oil-Dri
ODC
$1.27B
| $8.1M | ﹤0.01% |
217,206
+9,464
| +5% | +$326K |
|
2449
Northeast Bank
NBN
$1.16B
| $8.1M | ﹤0.01% |
146,319
+3,837
| +3% | +$205K |
|
2450
Playtika
PLTK
$961M
| $8.08M | ﹤0.01% |
1,144,991
+49,166
| +4% | +$362K |
|
Similar funds
Geode Capital Management's Q1 2024 Portfolio in Review
As of Q1 2024, Geode Capital Management held 4,738 positions worth $1.08T, up 13% from $956B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Geode Capital Management deployed $32.6B of net new capital in Q1 2024, opening 85 new positions and adding to 3,720 existing holdings. Its largest new stake was Solventum: 2,733,775 shares worth $0.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Amgen, an estimated $204M trimmed.
- Geode Capital Management's largest Q1 2024 buy was Solventum: 2,733,775 shares worth $0.
- Geode Capital Management added most to NVIDIA in Q1 2024, an estimated $1.81B increase.
- Geode Capital Management's biggest Q1 2024 reduction was Amgen, cutting an estimated $204M.
- Geode Capital Management fully exited Splunk Inc in Q1 2024, selling an estimated $373M.
- Geode Capital Management's ten largest holdings make up 28% of its $1.08T portfolio in Q1 2024.
- Geode Capital Management opened 85 new positions and closed 123 in Q1 2024.
- Geode Capital Management's portfolio value rose 13% quarter-over-quarter to $1.08T.
Based on Geode Capital Management's 13F filing for Q1 2024, filed 13 May 2024.